Fair enough. But as a side note, because this is one of those things that you always hope is the Holy Grail, I made a couple of calls to learn more about it. I was told off the record that most of the people in the trial are coming from he ranks of those with untreatable terminal disease. That is essence means that while they have qualified with the FDA for the investigation, the data is so preliminary that they have no idea even of how much drug to give a patient, let alone if it will work. This is how it always begins. You have to start somewhere, and that point is with people who have nothing to lose. I commend those patients in the trial not only for their desire to fight on, but for their willingness to help advance the science in spite of the fact that the odds of it working for them are so small.